The Clorox Company (CLX)

Cash ratio

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash and cash equivalents US$ in thousands 226,000 290,000 278,000 202,000 219,000 355,000 518,000 367,000 242,000 168,000 278,000 183,000 241,000 192,000 210,000 319,000 492,000 732,000 860,000 871,000
Short-term investments US$ in thousands 4,000 63,000 24,000 26,000
Total current liabilities US$ in thousands 2,155,000 1,730,000 1,579,000 1,574,000 1,846,000 2,022,000 2,228,000 1,917,000 1,996,000 1,878,000 2,010,000 1,784,000 2,643,000 2,596,000 2,639,000 2,056,000 1,819,000 1,738,000 1,516,000 1,418,000
Cash ratio 0.10 0.17 0.18 0.13 0.12 0.18 0.23 0.19 0.12 0.09 0.14 0.10 0.12 0.08 0.09 0.16 0.27 0.42 0.57 0.61

March 31, 2025 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($226,000K + $—K) ÷ $2,155,000K
= 0.10

The Clorox Company’s cash ratio demonstrates notable fluctuations over the analyzed period from June 2020 to March 2025. Initially, the ratio was relatively high at 0.61 as of June 30, 2020, indicating a solid liquidity position with cash and cash equivalents covering approximately 61% of current liabilities. This ratio declined sharply through the subsequent quarters, reaching its nadir at 0.08 as of December 31, 2021, reflecting a substantial reduction in liquid assets relative to current liabilities.

From early 2022 onward, the cash ratio showed signs of modest recovery, oscillating between approximately 0.09 and 0.23. Notably, the ratio increased to about 0.23 as of September 30, 2023, suggesting improved liquidity, although it remained significantly below the high levels observed at the start of the period. The overall trend points toward a decline in immediate liquidity within the company’s asset structure, implying that a decreasing proportion of current liabilities was covered by cash and cash equivalents.

The broad pattern indicates that Clorox experienced a reduction in its cash holdings relative to current liabilities during the initial years, possibly due to strategic investments, increased working capital needs, or shifts in short-term liquidity management. The partial recovery in the latter part of the period suggests efforts to bolster liquidity, but the ratios still reflect a moderate liquidity profile rather than a highly liquid position. Over the full span, the cash ratio ranged from a high of 0.61 to a low of 0.08, underscoring a significant decrease in immediate cash coverage over time, with recent ratios generally staying below 0.20.